{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:47:45Z","timestamp":1790387265820,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T00:00:00Z","timestamp":1660435200000},"content-version":"am","delay-in-days":194,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Neurobiology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.conb.2021.07.005","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T12:11:25Z","timestamp":1628943085000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Genetics in hereditary spastic paraplegias: Essential but not enough"],"prefix":"10.1016","volume":"72","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Darios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Coarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conb.2021.07.005_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","article-title":"Classification of the hereditary ataxias and paraplegias","volume":"1","author":"Harding","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.conb.2021.07.005_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neurol.2017.03.034","article-title":"Hereditary spastic paraplegia: more than an upper motor neuron disease","volume":"173","author":"Parodi","year":"2017","journal-title":"Rev Neurol"},{"key":"10.1016\/j.conb.2021.07.005_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.conb.2018.04.025","article-title":"Converging cellular themes for the hereditary spastic paraplegias","volume":"51","author":"Blackstone","year":"2018","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.conb.2021.07.005_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fnins.2020.00074","article-title":"Lipids in the physiopathology of hereditary spastic paraplegias","volume":"14","author":"Darios","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.conb.2021.07.005_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007550","article-title":"Progressive ataxia of Charolais cattle highlights a role of KIF1C in sustainable myelination","volume":"14","author":"Duchesne","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib6","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1073\/pnas.1112368109","article-title":"Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration","volume":"109","author":"Dehay","year":"2012","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.conb.2021.07.005_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003988","article-title":"A\u00a0hereditary spastic paraplegia mouse model supports a role of ZFYVE26\/SPASTIZIN for the endolysosomal system","volume":"9","author":"Khundadze","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005454","article-title":"In\u00a0vivo evidence for lysosome depletion and impaired autophagic clearance in hereditary spastic paraplegia type SPG11","volume":"11","author":"Varga","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2017.02.007","article-title":"Loss of spatacsin function alters lysosomal lipid clearance leading to upper and lower motor neuron degeneration","volume":"102","author":"Branchu","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2021.07.005_bib10","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1093\/hmg\/ddv220","article-title":"Loss of AP-5 results in accumulation of aberrant endolysosomes: defining a new type of lysosomal storage disease","volume":"24","author":"Hirst","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/jmedgenet-2012-100742","article-title":"A\u00a0founder mutation in Vps37A causes autosomal recessive complex hereditary spastic paraparesis","volume":"49","author":"Zivony-Elboum","year":"2012","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajhg.2019.03.001","article-title":"Truncating mutations in UBAP1 cause hereditary spastic paraplegia","volume":"104","author":"Farazi Fard","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib13","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/brain\/awz158","article-title":"Stop-gain mutations in UBAP1 cause pure autosomal-dominant spastic paraplegia","volume":"142","author":"Lin","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.07.005_bib14","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.celrep.2013.04.015","article-title":"A\u00a0conserved role for atlastin GTPases in regulating lipid droplet size","volume":"3","author":"Klemm","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.conb.2021.07.005_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005149","article-title":"Spastin binds to lipid droplets and affects lipid metabolism","volume":"11","author":"Papadopoulos","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw315","article-title":"Reep1 null mice reveal a converging role for hereditary spastic paraplegia proteins in lipid droplet regulation","author":"Renvois\u00e9","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201898947","article-title":"The assembly of lipid droplets and their roles in challenged cells","volume":"37","author":"Henne","year":"2018","journal-title":"EMBO J"},{"key":"10.1016\/j.conb.2021.07.005_bib18","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.1413706111","article-title":"The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase","volume":"111","author":"Inloes","year":"2014","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.conb.2021.07.005_bib19","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1093\/hmg\/dds191","article-title":"Spg20\u2212\/\u2212 mice reveal multimodal functions for Troyer syndrome protein spartin in lipid droplet maintenance, cytokinesis and BMP signaling","volume":"21","author":"Renvois\u00e9","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.005_sref20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2020.06.015","article-title":"Bi-allelic HPDL variants cause a neurodegenerative disease ranging from neonatal encephalopathy to adolescent-onset spastic paraplegia","volume":"107","author":"Husain","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ymgme.2017.10.004","article-title":"New insights into the phenotype of FARS2 deficiency","volume":"122","author":"Vantroys","year":"2017","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.conb.2021.07.005_sref22","doi-asserted-by":"crossref","first-page":"e2679","DOI":"10.1212\/WNL.0000000000007606","article-title":"Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7","volume":"92","author":"Coarelli","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2021.07.005_bib23","doi-asserted-by":"crossref","first-page":"102142","DOI":"10.1016\/j.ceca.2019.102142","article-title":"The emerging link between IP3 receptor turnover and Hereditary Spastic Paraplegia","volume":"86","author":"Gao","year":"2020","journal-title":"Cell Calcium"},{"key":"10.1016\/j.conb.2021.07.005_sref24","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1038\/s41467-019-12620-9","article-title":"Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegia","volume":"10","author":"Wagner","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2021.07.005_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw139","article-title":"ER-shaping proteins are required for ER and mitochondrial network organization in motor neurons","author":"Fowler","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib26","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1212\/NXG.0000000000000032","article-title":"Recessive REEP1 mutation is associated with congenital axonal neuropathy and diaphragmatic palsy","volume":"1","author":"Schottmann","year":"2015","journal-title":"Neurol Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib27","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1172\/JCI65665","article-title":"A\u00a0spastic paraplegia mouse model reveals REEP1-dependent ER shaping","volume":"123","author":"Beetz","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.conb.2021.07.005_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajhg.2013.12.005","article-title":"Loss of association of REEP2 with membranes leads to hereditary spastic paraplegia","volume":"94","author":"Esteves","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.conb.2021.07.005_bib29","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/brain\/119.5.1487","article-title":"Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2","volume":"119","author":"D\u00fcrr","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.07.005_sref30","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1093\/brain\/awy285","article-title":"Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex","volume":"141","author":"Parodi","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.07.005_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10048-004-0186-z","article-title":"Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations","volume":"5","author":"Svenson","year":"2004","journal-title":"Neurogenetics"},{"key":"10.1016\/j.conb.2021.07.005_bib32","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1093\/brain\/awx273","article-title":"Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial","volume":"140","author":"Sch\u00f6ls","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.07.005_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/brain\/awx297","article-title":"Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5","volume":"141","author":"Marelli","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.07.005_bib34","article-title":"Thalamic atrophy in patients with pure hereditary spastic paraplegia type 4","author":"Navas-S\u00e1nchez","year":"2021","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.conb.2021.07.005_bib35","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.conb.2021.07.005_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2021.07.005_bib37","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.conb.2021.07.005_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.51355","article-title":"Comparison of Simoa TM and Ella TM to assess serum neurofilament-light chain in multiple sclerosis","author":"Gauthier","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.conb.2021.07.005_bib39","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/acn3.583","article-title":"Serum neurofilament light chain is increased in hereditary spastic paraplegias","volume":"5","author":"Wilke","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.conb.2021.07.005_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.51358","article-title":"Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia","author":"Kessler","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.conb.2021.07.005_bib41","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2021.07.005_bib42","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/acn3.51188","article-title":"Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy","volume":"7","author":"Ballegoij","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.conb.2021.07.005_sref43","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41467-021-22114-2","article-title":"Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy","volume":"12","author":"Weinhofer","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2021.07.005_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12356","article-title":"MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: meta-analysis and consensus guidelines","author":"Mallack","year":"2021","journal-title":"J\u00a0Inherit Metab Dis"}],"container-title":["Current Opinion in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438821000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438821000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:00:37Z","timestamp":1760706037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959438821000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":44,"alternative-id":["S0959438821000751"],"URL":"https:\/\/doi.org\/10.1016\/j.conb.2021.07.005","relation":{},"ISSN":["0959-4388"],"issn-type":[{"value":"0959-4388","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics in hereditary spastic paraplegias: Essential but not enough","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conb.2021.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}